Cellular Reprogramming in Early Hormone-Positive Breast Cancer
In a groundbreaking study that could redefine therapeutic strategies for hormone receptor-positive breast cancer, researchers have uncovered profound cellular reprogramming occurring during combined anti-PD-1 immunotherapy...















